FDA inspection
Johnson & Johnson Pharmaceutical Research & Development, LLC: FDA inspection ending Apr 14, 2009
FDA inspection 575843 · Voluntary Action Indicated (VAI) · Raritan, NJ
Key facts
| Inspection ID | 575843 |
|---|---|
| Firm | Johnson & Johnson Pharmaceutical Research & Development, LLC |
| FEI number | 3006192174 |
| Address | 920 U.S. Highway 202, P.O. Box 300 |
| City | Raritan |
| State | NJ |
| ZIP | 08869 |
| Country | United States |
| Fiscal year | 2009 |
| Inspection end date | Apr 14, 2009 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
| Warning letter | 64044 |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data